Globus Medical (GMED) Reports In-Line Q3 EPS, Beats on Revenues; Reaffirms FY17 EPS/Revenue Guidance

Go back to Globus Medical (GMED) Reports In-Line Q3 EPS, Beats on Revenues; Reaffirms FY17 EPS/Revenue Guidance
GLOBUS MEDICAL, Inc. (NYSE: GMED) Delayed: 80.26 +0.14 (0.17%)
Previous Close $80.12    52 Week High $28.60 
Open $79.99    52 Week Low $19.25 
Day High $80.26    P/E 109.95 
Day Low $78.25    EPS $0.73 
Volume 368,891